Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.16
-0.72 (-2.68%)
At close: Dec 26, 2025, 4:00 PM EST
28.00
+1.84 (7.03%)
After-hours: Dec 26, 2025, 7:46 PM EST
Immunovant Employees
Immunovant had 362 employees as of March 31, 2025. The number of employees increased by 155 or 74.88% compared to the previous year.
Employees
362
Change (1Y)
155
Growth (1Y)
74.88%
Revenue / Employee
n/a
Profits / Employee
-$1,283,663
Market Cap
5.30B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 362 | 155 | 74.88% |
| Mar 31, 2024 | 207 | 43 | 26.22% |
| Mar 31, 2023 | 164 | 40 | 32.26% |
| Mar 31, 2022 | 124 | 56 | 82.35% |
| Mar 31, 2021 | 68 | 26 | 61.90% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMVT News
- 15 days ago - Immunovant: 'Buy' On Competitive Batoclimab Landscape And IMVT-1402 Advancement - Seeking Alpha
- 17 days ago - Immunovant Announces Pricing of $550 Million Common Stock Financing - GlobeNewsWire
- 6 weeks ago - Immunovant, Inc. (IMVT) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025 - GlobeNewsWire
- 2 months ago - Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025 - GlobeNewsWire
- 4 months ago - Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients - GlobeNewsWire
- 4 months ago - IMVT Investors Have Opportunity to Join Immunovant, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 4 months ago - Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025 - GlobeNewsWire